12:00 AM
 | 
Mar 17, 2014
 |  BC Week In Review  |  Company News  |  Deals

Activaero, Vectura deal

Pulmonary play Vectura Group is acquiring drug delivery company Activaero for €130 million ($180.6 million). The amount comprises €45 million ($62.5 million) up front in cash and €50 million ($69.5 million) in new Vectura shares, plus €35 million ($48.6 million)...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >